Man Group’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Hold
0
-$150K 2054
2023
Q1
Sell
-102,396
Closed -$120K 1855
2022
Q4
$120K Buy
+102,396
New +$120K ﹤0.01% 1878
2021
Q1
Sell
-23,788
Closed -$42K 1926
2020
Q4
$42K Buy
+23,788
New +$42K ﹤0.01% 1794